Innospark Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample.
BiotechDigital HealthFemTech
Co-investorsAmboy Street VenturesDria VenturesBlue CollectiveCompany VenturesMBX Capital
All-in-one AI vision system enabling autonomous operation and quality control in plastic injection molding.
Edward Schneeweiss(Founder)inSebastian G Schneeweiss(Founder)in
Co-investorsBlue CollectiveGlasswing VenturesArgon VenturesFounder Collective
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.